| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Olfactomedin-like protein 2A, Photomedin-1, OLFML2A |
| Entrez GeneID | 169611 |
| WB Predicted band size | 73.1kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This OLFML2A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 6-34 amino acids from the N-terminal region of human OLFML2A. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是3篇关于OLFML2A(N-term)抗体的参考文献，按研究领域分类整理：
1. **文献名称**：OLFML2A在肿瘤相关成纤维细胞中的表达调控及其促血管生成作用
**作者**：Smith J, et al. (2016)
**摘要**：该研究利用针对OLFML2A N端结构域的多克隆抗体，通过免疫组化技术证实了OLFML2A在结肠癌肿瘤微环境中的特异性表达模式。研究发现OLFML2A通过调控VEGF信号通路促进肿瘤血管新生。
2. **文献名称**：发育过程中OLFML2A的时空表达图谱
**作者**：Zhang L, et al. (2018)
**摘要**：研究团队使用OLFML2A N-term单克隆抗体进行Western blot和免疫荧光分析，首次绘制了该蛋白在小鼠胚胎视网膜发育过程中的动态表达图谱，提示其可能在神经嵴细胞迁移中起重要作用。
3. **文献名称**：OLFML2A作为子痫前期新型生物标志物的验证研究
**作者**：Lee S, et al. (2020)
**摘要**：通过N端特异性抗体建立ELISA检测体系，在孕妇血清样本中发现OLFML2A水平与子痫前期发病风险呈显著正相关(p<0.001)，ROC曲线下面积达0.87.具有较高诊断价值。
注：以上文献为领域典型研究方向示例，实际文献需通过PubMed、Web of Science等数据库用关键词"OLFML2A antibody"+"N-terminal"检索获取。建议优先选择近五年内发表的、抗体验证数据完整(如包含WB/IHC阳性对照图)的研究论文。
The OLFML2A (N-term) antibody is a specialized tool designed to target the N-terminal region of Olfactomedin-like protein 2A (OLFML2A), a secreted glycoprotein belonging to the olfactomedin domain-containing family. OLFML2A is implicated in modulating extracellular matrix organization, cell adhesion, and signaling pathways, particularly in developmental and pathological contexts. It is expressed in various tissues, including the eye, brain, and placenta, and has been linked to angiogenesis, immune regulation, and cancer progression. Dysregulation of OLFML2A has been observed in diseases such as glioblastoma, colorectal cancer, and age-related macular degeneration.
The N-terminal region of OLFML2A is critical for its structural stability and interaction with ligands or receptors, such as BMP-1/Tolloid proteases or integrins. Antibodies targeting this domain enable researchers to study OLFML2A’s expression patterns, post-translational modifications, and functional mechanisms in both physiological and disease states. They are widely used in techniques like Western blotting, immunohistochemistry, and immunofluorescence to visualize protein localization and quantify expression levels. Additionally, OLFML2A (N-term) antibodies contribute to exploring its role as a potential biomarker or therapeutic target in cancer and ocular disorders. Their specificity for the N-terminus ensures minimal cross-reactivity with homologous proteins, making them valuable for precise molecular investigations.
×
